He spent 2 years at ICI-Pharma, followed by 8 years at Synthelabo, a division of L ... In June 2009, he joined Sanofi Pasteur as Vice President, Franchise &amp, Global Marketing Operations ...

Drug Metab Dispos. 1900; 18:138-45. k Ambien (zolpidem) package insert. New York: Sanofi-Synthelabo; 2004 Mar. April D. Miller, Pharm.D., is Critical Care Specialty Resident and Chief Resident ...

It is made by Sanofi-Synthelabo and Bristol-Myers Squibb, who funded the study. Like aspirin, Plavix affects the blood's clotting action, making it less likely that life-threatening clots will ...

2000 - The company's equal joint venture with Rottapharm of Italy called Earth Wind and Fire Pharmaceuticals (EWF) has signed an agreement with French company Sanofi-Synthelabo to market the ...

Ltd to their joint venture partner Sanofi Synthelabo, France. Also, they transferred their entire equity holding of 1,95,04,691 shares in the sick industrial undertaking Torrent Gujarat Biotech ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% controlling stake in its consumer health business Opella. With the French ...

Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing ...

Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to potentially sell and purchase a 50% controlling stake in Opella, Sanofi ...

PARIS, Oct 16 (Reuters) - French unions have called on workers at Sanofi (SASY.PA), opens new tab to strike from Thursday to protest a planned sale of the pharmaceutical group's consumer health ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

A consortium including French private equity firm PAI Partners has raised its offer for Sanofi's consumer health business, Opella, according to sources. The group has revised its bid by €200m ...